External contributor: Kamal Mahtani
University of Oxford
Papers by Kamal Mahtani
- COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time.
- COMPare: Qualitative analysis of researchers' responses to critical correspondence on a cohort of 58 misreported trials
- Pharmaceutical companies' policies on access to trial data, results, and methods: audit study.